Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen Looks at Former J&J Exec as Potential CEO Candidate
BioSpace
Mon, 10/10/22 - 07:00 pm
Tags:
Biogen, Pharma CEOs, JNJ, Mathai Mammen
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Tags:
Biogen, Denali Therapeutics, Parkinson's Disease, clinical trials, BIIB122
Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage
Medical Marketing and Media
Thu, 09/29/22 - 10:23 am
Tags:
Medicare, Medicare Part B, Biogen, Aduhelm
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Tags:
Biogen, Eisai, Alzheimer's disease, Arrowhead Pharmaceuticals, Takeda, RNAi, Madrigal, NASH, Ascendis, FDA
Lecanemab can; now the wait for details begins
EP Vantage
Wed, 09/28/22 - 11:45 am
Tags:
Biogen, Eisai, lecanemab, clinical trials, Alzheimer's disease
A Biotech Breakthrough Means Big Gains for These 2 Stocks
Motley Fool
Wed, 09/28/22 - 11:02 am
Tags:
Eli Lilly, Biogen, Alzheimer's disease, lecanemab, donanemab
Biogen/Eisai Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
Stat
Wed, 09/28/22 - 12:04 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, lecanemab
Biogen pays $900M to settle wide-ranging physician kickback claims
Endpoints
Tue, 09/27/22 - 10:40 am
Tags:
Biogen, whistleblowers, whistleblower lawsuits, legal, kickbacks
Biogen bolsters case for ALS drug under FDA review with new published data
MedCity News
Fri, 09/23/22 - 10:36 am
Tags:
Biogen, ALS, FDA, tofersen
Biogen nets $592M in Boston real estate sale as cost-cutting campaign rolls on
Fierce Pharma
Wed, 09/21/22 - 07:53 pm
Tags:
Biogen, Aduhelm, Massachusetts, Boston, real estate, Cambridge
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Tags:
Biogen, Novartis, Sandoz, biosimilars, Tysabri, MS, multiple sclerosis
Ahead of FDA filing, Sage and Biogen tout more data in hopes of alleviating durability concerns
Endpoints
Mon, 09/19/22 - 09:53 pm
Tags:
SAGE Therapeutics, Biogen, major depressive disorder, zuranolone
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Fri, 09/9/22 - 11:07 am
Tags:
Biogen, litifilimab, lupus, systemic lupus erythematosus, monoclonal antibodies, clinical trials
Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
Tags:
painkillers, Acadia, Eli Lilly, Ampio Pharmaceuticals, Aptinyx, Eliem Therapeutics, Vertanical, Teva Pharamceutical, Regeneron, Vivozon, Vertex Pharmaceuticals, Biogen
Aduhelm’s loss is a win for value-based drug pricing
MedCity News
Thu, 08/11/22 - 10:39 am
Tags:
Biogen, Aduhelm, value-based pricing, drug pricing, Alzheimer's disease
Amid $1B downsizing, Biogen lists Boston-area office space for sublease
Fierce Pharma
Wed, 08/10/22 - 10:51 am
Tags:
Biogen, Boston, Cambridge MA
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Biogen deflects claims it misled shareholders about Aduhelm's success
Fierce Pharma
Mon, 08/1/22 - 10:27 am
Tags:
Biogen, Aduhelm, Alzheimer's disease
Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US
Fierce Pharma
Wed, 07/27/22 - 10:58 am
Tags:
Novartis, Biogen, multiple sclerosis, MS, Tysabri, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.